148 related articles for article (PubMed ID: 1554500)
1. Severe combined immunodeficiencies.
Fischer A
Immunodefic Rev; 1992; 3(2):83-100. PubMed ID: 1554500
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
3. [Gene therapy for hereditary immunodeficiencies].
Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
5. Defining combined immunodeficiency.
Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
[TBL] [Abstract][Full Text] [Related]
6. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
[TBL] [Abstract][Full Text] [Related]
7. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
8. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficiency.
Hirschhorn R
Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
[TBL] [Abstract][Full Text] [Related]
10. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
12. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.
Felgentreff K; Perez-Becker R; Speckmann C; Schwarz K; Kalwak K; Markelj G; Avcin T; Qasim W; Davies EG; Niehues T; Ehl S
Clin Immunol; 2011 Oct; 141(1):73-82. PubMed ID: 21664875
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor diversity in severe combined immunodeficiency following HLA-haploidentical bone marrow transplantation.
Knobloch C; Friedrich W
Bone Marrow Transplant; 1991 Nov; 8(5):383-7. PubMed ID: 1768974
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiency is a tough nut to CRAC: the importance of calcium flux in T cell activation.
Carroll HP; McNaull BB; Gadina M
Mol Interv; 2006 Oct; 6(5):253-6. PubMed ID: 17035665
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of severe combined immunodeficiency disease.
Gelfand EW; Dosch HM
Birth Defects Orig Artic Ser; 1983; 19(3):65-72. PubMed ID: 6360247
[TBL] [Abstract][Full Text] [Related]
17. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Weinberg K; Hershfield MS; Bastian J; Kohn D; Sender L; Parkman R; Lenarsky C
J Clin Invest; 1993 Aug; 92(2):596-602. PubMed ID: 8349799
[TBL] [Abstract][Full Text] [Related]
19. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
[TBL] [Abstract][Full Text] [Related]
20. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]